A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned

Overview of attention for article published in British Journal of Haematology, May 2025

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,217 followers.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.